Ofloxacin Ratiopharm

Ofloxacin, the active ingredient in Ofloxacin Ratiopharm, is a fluoroquinolone presented as an ophthalmic solution for ocular use. It treats bacterial conjunctivitis, keratitis, blepharitis and other ocular bacterial infections in adults and children as prescribed.

GNH USA supplies Ofloxacin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacin is a fluoroquinolone antibacterial used to treat bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and resolves redness and discharge. - Keratitis: eradicates causative bacteria and promotes corneal healing. - Blepharitis: eliminates bacterial involvement and improves eyelid inflammation.

Adverse ocular reactions may occur with use of Ofloxacin ophthalmic solution.

Common Side Effects: - Burning or stinging sensation upon instillation. - Transient eye redness. - Tearing or increased lacrimation. - Blurred vision temporarily. - Foreign body sensation. - Mild eyelid edema.

Serious or Rare Side Effects: - Allergic reactions such as eyelid swelling or rash. - Severe eye pain or worsening inflammation. - Vision loss or sudden decrease in visual acuity. - Corneal ulceration or perforation. - Stevens‑Johnson syndrome or toxic epidermal necrolysis (rare). - Systemic hypersensitivity reactions.

Before using Ofloxacin ophthalmic solution, consider the following precautions.

- Allergy assessment: verify no known hypersensitivity to fluoroquinolones. - Contact lens use: avoid wearing lenses until treatment is completed. - Pregnancy: use only if clearly needed, as it is classified as pregnancy category C. - Systemic absorption: monitor for systemic fluoroquinolone effects during prolonged therapy. - Store at room temperature: keep in the original container, protect from light and moisture.

Ofloxacin ophthalmic solution may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent systemic use may increase risk of tendon rupture. - Corticosteroid eye drops: may mask infection progression. - Anticholinergic agents: may increase intra‑ocular pressure.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may affect corneal healing. - Herbal supplements containing quinine: potential additive toxicity.